PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Qatar Airways Cargo and DoKaSch sign master agreement OPTICOOLER® ACTIVE CONTAINER NOW AVAILABLE FOR PHARMA SHIPMENTS

DoKaSch Temperature Solutions, provider of climate-controlled solutions for air shipment of temperature-sensitive cargo, expands its customer base by signing an agreement with Qatar Airways Cargo. This enables customers to directly lease the newest technology of Active Containers, RKN and RAP Opticooler®, from Qatar Airways Cargo all around the globe.
Qatar Airways’ Chief Officer Cargo, Mr. Ulrich Ogiermann said, “We understand the intricacies of a seamless cool chain and always aim to provide value to our customers. Through this agreement with DoKaSch Temperature Solutions, we have now expanded our active container offering for customers, presenting our business partners with more options to transport their pharmaceuticals globally.”
Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, adds: “We are very pleased to make our Opticooler® available through the number three biggest cargo airline worldwide. We are convinced that with the extensive and fast growing flight network of Qatar Airways and our joint commitment to quality and customer satisfaction, this cooperation will provide a great solution for the global pharma cool chain.”
DoKaSch Temperature Solutions runs a well-recognized fleet of Active Cool Containers RAP and RKN Opticooler. Both are equipped with electric/battery powered cooling compressors and heaters, and require no dry ice. This high-end-packaging-solution safeguards the efficacy of vital pharmaceuticals throughout global transportation chains.
Valued for their exceptional reliability and performance in any climate, these active containers keep the cargo within a temperature range of 2 to 8 degree celsius or 15 to 25 degree celsius. The system features a straightforward touchscreen interface, making the temperature setting extremely dependable.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026